This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Lars Geiger, PhD
Global Director of Project Management Drug Substance at Evonik Health Care


Dr. Lars Geiger; Global Director of Project Management Drug Substance at Evonik’s Health Care product line. Has been working in Evonik’s pharma CDMO business line in different R&D and project management roles in Germany and the USA for more than18 years. Organic chemist by training, received the diploma from the University of Cologne and graduated at the University of Würzburg in 2004 in the group of Prof. Dr. Carsten Schmuck, in the field of bioorganic chemistry. Afterwards, he conducted a postdoctoral stay at the Massachusetts Institute of Technology (MIT) in Boston, USA, in the group of Prof. Dr. Timothy M. Swager, where he worked on conduction polymers.

In his career he led various large pharma projects at Evonik including the development of the lipid production for BioNTech. In his current role, he is heading the customer project management organization in the drug product CDMO business, focusing on Active Pharmaceutical Ingredient (API) manufacturing.

Agenda Sessions

  • Plant-based Squalene for Parenteral Applications